Report Summary

Taro Pharmaceuticals Industries Ltd Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Taro Pharmaceutical Industries (Taro) develops, manufactures and markets prescription and over-the-counter (OTC) pharmaceutical products. The company also develops and manufactures active pharmaceutical ingredients (APIs) primarily for use in its finished dosage form products. The company primarily operates in the US, Israel and Canada. It is headquartered in Yakum, Israel and employs about 1,150 people. The company recorded revenues of $297.7 million during the fiscal year ended December 2005, an increase of 14% over 2004. The operating profit of the company was $15.2 million during fiscal year 2005, as compared to an operating loss of $24 million in 2004. The net profit was $5.7 million in fiscal year 2005, as compared to a net loss of $31.4 million in 2004. Taro filed its Form 20-F for fiscal 2005 on March 2007. The company had to restate its financial results for fiscals 2003 and 2004 due to an ongoing investigation on the company's financials. The company has not fixed any timeline for filing its Form 20-F for fiscal 2006.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available